Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Capital Expenditures: 2022-2024

Historic Capital Expenditures for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $289,000.

  • Orchestra BioMed Holdings' Capital Expenditures rose 355.88% to $310,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $562,000, marking a year-over-year increase of 212.22%. This contributed to the annual value of $289,000 for FY2024, which is 270.51% up from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Capital Expenditures stood at $289,000 for FY2024, which was up 270.51% from $78,000 recorded in FY2023.
  • Orchestra BioMed Holdings' 5-year Capital Expenditures high stood at $591,000 for FY2022, and its period low was $78,000 during FY2023.
  • Its 3-year average for Capital Expenditures is $319,333, with a median of $289,000 in 2024.
  • Its Capital Expenditures has fluctuated over the past 5 years, first slumped by 86.80% in 2023, then spiked by 270.51% in 2024.
  • Over the past 3 years, Orchestra BioMed Holdings' Capital Expenditures (Yearly) stood at $591,000 in 2022, then tumbled by 86.80% to $78,000 in 2023, then soared by 270.51% to $289,000 in 2024.